U.S. flag

An official website of the United States government

NM_148919.4(PSMB8):c.224C>T (p.Thr75Met) AND PSMB8-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003411802.4

Allele description [Variation Report for NM_148919.4(PSMB8):c.224C>T (p.Thr75Met)]

NM_148919.4(PSMB8):c.224C>T (p.Thr75Met)

Gene:
PSMB8:proteasome 20S subunit beta 8 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.32
Genomic location:
Preferred name:
NM_148919.4(PSMB8):c.224C>T (p.Thr75Met)
HGVS:
  • NC_000006.12:g.32843013G>A
  • NG_009793.3:g.758C>T
  • NG_028165.1:g.6923C>T
  • NM_004159.5:c.212C>T
  • NM_148919.4:c.224C>TMANE SELECT
  • NP_004150.1:p.Thr71Met
  • NP_683720.2:p.Thr75Met
  • LRG_1328t1:c.224C>T
  • LRG_1328t2:c.212C>T
  • LRG_1328:g.6923C>T
  • LRG_1328p1:p.Thr75Met
  • LRG_1328p2:p.Thr71Met
  • NC_000006.11:g.32810790G>A
  • NM_148919.3:c.224C>T
Note:
ClinGen staff contributed the HGVS expression for this variant.
Protein change:
T71M; THR75MET
Links:
OMIM: 177046.0001; dbSNP: rs748082671
NCBI 1000 Genomes Browser:
rs748082671
Molecular consequence:
  • NM_004159.5:c.212C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_148919.4:c.224C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
PSMB8-related disorder
Synonyms:
PSMB8-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004112984PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 13, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004112984.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The PSMB8 c.224C>T variant is predicted to result in the amino acid substitution p.Thr75Met. This variant has been reported in patients with joint contractures, muscle atrophy, microcytic anemia, and panniculitis induced lipodystrophy syndrome (JMP) and CANDLE syndrome (Agarwal et al. 2010. PubMed ID: 21129723; Brehm et al. 2015. PubMed ID: 26524591; Liu et al. 2012. PubMed ID: 21953331). Functional studies indicate the c.224C>T (p.Thr75Met) variant impairs proteosomal activity (Agarwal et al. 2010. PubMed ID: 21129723). This variant is interpreted as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024